Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Intra-Abdominal Infection”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Large-scale testing (Phase 3)Study completedNCT00389987
What this trial is testing

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

Who this might be right for
Complicated Intra-Abdominal Infections
Merck Sharp & Dohme LLC 300
Post-approval studies (Phase 4)Study completedNCT01721408
What this trial is testing

Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

Who this might be right for
Intra-abdominal Infection
Pfizer 470
Not applicableStudy completedNCT02364284
What this trial is testing

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

Who this might be right for
Urinary Tract Infection (cUTI)Intra-abdominal Infection (cIAI) andNosocomial Pneumonia (NP)
Pfizer 1,322
Post-approval studies (Phase 4)Study completedNCT00488306
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI

Who this might be right for
Abdominal Abscess
Wyeth is now a wholly owned subsidiary of Pfizer 50
Large-scale testing (Phase 3)Study completedNCT01644643
What this trial is testing

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Who this might be right for
Complicated Urinary Tract InfectionComplicated Intra-abdominal Infection
Pfizer 345
Large-scale testing (Phase 3)Study completedNCT00081744
What this trial is testing

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

Who this might be right for
Gram-Positive Bacterial InfectionsCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 850
Not applicableStudy completedNCT00488488
What this trial is testing

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

Who this might be right for
Infection
Pfizer 1,028
Large-scale testing (Phase 3)Study completedNCT00229060
What this trial is testing

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Who this might be right for
Bacterial Infections and MycosesAppendicitisCholecystitis+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 483
Not applicableStudy completedNCT00683332
What this trial is testing

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Who this might be right for
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections
Pfizer 621
Large-scale testing (Phase 3)Study completedNCT00210938
What this trial is testing

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

Who this might be right for
Bacterial Infections and MycosesAppendicitisCholecystitis+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 478
Testing effectiveness (Phase 2)Looking for participantsNCT05639647
What this trial is testing

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Who this might be right for
Gram-negative Bacterial Infections
Pfizer 48
Large-scale testing (Phase 3)Looking for participantsNCT05148702
What this trial is testing

EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.

Who this might be right for
Complicated Intra-abdominal Infection
Sarah Cockayne 1,166
Large-scale testing (Phase 3)Study completedNCT01726023
What this trial is testing

Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections

Who this might be right for
Complicated Intra-abdominal Infection
Pfizer 486
Large-scale testing (Phase 3)Study completedNCT01069900
What this trial is testing

Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection

Who this might be right for
Intraabdominal Infections
Bayer 458
Testing effectiveness (Phase 2)Study completedNCT02475733
What this trial is testing

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

Who this might be right for
Complicated Intra-abdominal Infections
Pfizer 83
Post-approval studies (Phase 4)Study completedNCT00044928
What this trial is testing

Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

Who this might be right for
Bacterial Infections
Wyeth is now a wholly owned subsidiary of Pfizer 262
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Large-scale testing (Phase 3)Study completedNCT04927312
What this trial is testing

Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection

Who this might be right for
Complicated Intra-abdominal Infection
Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT00752219
What this trial is testing

Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections

Who this might be right for
Complicated Intra-abdominal Infections
Pfizer 204
Testing effectiveness (Phase 2)Study completedNCT01506271
What this trial is testing

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Who this might be right for
Intra-abdominal Infections
Merck Sharp & Dohme LLC 351
Load More Results